Abstract
Objective
To examine the health-related quality of life (HRQoL) and factors associated with HRQoL in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) using two generic preference-based HRQoL instruments, EQ-5D (plus EQ-VAS) and SF-6D, with the results compared with general population.
Method
CP/CPPS patients were recruited from two tertiary referral hospitals, and the general populations were randomly approached. After informed consent, subjects were interviewed using EQ-5D, EQ-VAS and SF-6D, and their socio-demographic and medical information was solicited.
Results
Compared to the general population (n = 364), CP/CPPS patients (n = 268) reported significantly worse HRQoL with median score of the EQ-5D utility index (0.73 vs. 0.85), SF-6D utility index (0.76 vs. 0.81), and EQ-VAS (70.0 vs. 85.0). Multiple linear regression analyses showed pain symptom had the strongest predictive power for HRQoL, compared to symptom duration and urinary symptom. Socio-demographic factors and comorbidities did not significantly contribute to poorer HRQoL.
Conclusion
CP/CPPS patients experienced deteriorated HRQoL with lower health-related utility scores compared to general population, and pain severity was the main physical symptom predicting decreased health-related utility. Further studies are needed to provide the reference utility index for the comparison and better characterizing the influence of geographic and cultural factors on variation of health-related utility of CP/CPPS patients.
Similar content being viewed by others
Abbreviations
- CP/CPPS:
-
Chronic prostatitis/chronic pelvic pain syndrome
- CUA:
-
Cost-utility analysis
- HRQoL:
-
Health-related quality of life
- MID:
-
Minimally important difference
- MLR:
-
Multiple linear regressions
- NIH-CPSI:
-
National Institutes of Health Chronic Prostatitis Symptom Index
- IQR:
-
Interquartile range
References
Liang, C. Z., Li, H. J., Wang, Z. P., Xing, J. P., Hu, W. L., Zhang, T. F., et al. (2009). The prevalence of prostatitis-like symptoms in China. Journal of Urology, 182(2), 558–563.
Ku, J. H., Kim, S. W., & Paick, J. S. (2005). Epidemiologic risk factors for chronic prostatitis. International Journal of Andrology, 28(6), 317–327.
Krieger, J. N., Egan, K. J., Ross, S. O., Jacobs, R., & Berger, R. E. (1996). Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”. Urology, 48(5), 715–721.
Alexander, R. B., & Trissel, D. (1996). Chronic prostatitis: results of an Internet survey. Urology, 48(4), 568–574.
Tripp, D. A., Curtis Nickel, J., Landis, J. R., Wang, Y. L., & Knauss, J. S. (2004). Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU International, 94(9), 1279–1282.
McNaughton Collins, M. (2003). The impact of chronic prostatitis/chronic pelvic pain syndrome on patients. World Journal of Urology, 21(2), 86–89.
Calhoun, E. A., McNaughton Collins, M., Pontari, M. A., O’Leary, M., Leiby, B. E., Landis, R. J., et al. (2004). The economic impact of chronic prostatitis. Archives of Internal Medicine, 164(11), 1231–1236.
McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., et al. (2001). Quality of life is impaired in men with chronic prostatitis: The Chronic Prostatitis Collaborative Research Network. Journal of General Internal Medicine, 16(10), 656–662.
Ku, J. H., Kim, S. W., & Paick, J. S. (2005). Quality of life and psychological factors in chronic prostatitis/chronic pelvic pain syndrome. Urology, 66(4), 693–701.
National Institute for Clinical Excellence. (2008). Guide to the methods of health technology appraisal. London.
Australia Pharmaceutical Benefits Advisory Committee. (2006). Guidelines for preparing submissions to the PBAC. Canberra.
Ontario Ministry of Health and Long-term Care. (1994). Ontario guidelines for economic analysis of pharmaceutical products. Ontario.
Bao Peng, L., Qing Tan, C., Min Wan, X., & Cui, W. (2007). Cost-utility analysis in China: Differences and difficulties compared with developed countries. Pharmacoeconomics, 25(7), 619.
Propert, K. J., McNaughton-Collins, M., Leiby, B. E., O’Leary, M. P., Kusek, J. W., & Litwin, M. S. (2006). A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: The National Institutes of Health Chronic Prostatitis Cohort study. Journal of Urology, 175(2), 619–623.
Walz, J., Perrotte, P., Hutterer, G., Suardi, N., Jeldres, C., Benard, F., et al. (2007). Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU International, 100(6), 1307–1311.
Lam, C. L., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health, 11(2), 295–303.
Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: Results from a EuroQol study in Beijing, China. Quality of Life Research, 14(1), 119–132.
Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.
Schaeffer, A. J., Datta, N. S., Fowler, J. E., Jr., Krieger, J. N., Litwin, M. S., Nadler, R. B., et al. (2002). Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology, 60(6 Suppl), 1–4.
Litwin, M. S., McNaughton-Collins, M., Fowler, F. J., Jr., Nickel, J. C., Calhoun, E. A., Pontari, M. A., et al. (1999). The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. Journal of Urology, 162(2), 369–375.
Nickel, J. C. (2001). Special report on prostatitis: State of the art: Highlights of the Third Annual International Prostatitis Collaborative Network Meeting October 23–25, 2000, Washington, DC. Reviews in Urology, 3(2), 94–98.
Liang, C. Z., Li, H. J., Wang, Z. P., Xing, J. P., Hu, W. L., Zhang, T. F., et al. (2009). Treatment of chronic prostatitis in Chinese men. Asian Journal of Andrology, 11(2), 153–156.
Liang, C. Z., Zhang, X. J., Hao, Z. Y., Yang, S., Wang, D. B., Shi, H. Q., et al. (2004). An epidemiological study of patients with chronic prostatitis. BJU International, 94(4), 568–570.
Ku, J. H., Kwak, C., Oh, S. J., Lee, E., Lee, S. E., & Paick, J. S. (2004). Influence of pain and urinary symptoms on quality of life in young men with chronic prostatitis-like symptoms. International Journal of Urology, 11(7), 489–493.
Claxton, K. (1999). The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics, 18(3), 341–364.
Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes, 1, 4.
Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.
Luo, N., Chew, L. H., Fong, K. Y., Koh, D. R., Ng, S. C., Yoon, K. H., et al. (2003). Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study. Health Qual Life Outcomes, 1, 7.
Rothman, K. J. (1990). No adjustments are needed for multiple comparisons. Epidemiology, 1(1), 43–46.
Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care, 45(12), 1162–1170.
Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.
Johnson, J. A., & Coons, S. J. (1998). Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research, 7(2), 155–166.
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ, 316(7133), 736–741.
Guess, H. A., Chute, C. G., Garraway, W. M., Girman, C. J., Panser, L. A., Lee, R. J., et al. (1993). Similar levels of urological symptoms have similar impact on Scottish and American men—although Scots report less symptoms. Journal of Urology, 150, 1701–1705.
Li, S. C. (2007). How to improve pharmacoeconomic data generalisability between different countries. Expert Opinion on Pharmacotherapy, 8(10), 1409–1413.
Author information
Authors and Affiliations
Corresponding author
Additional information
Jiu-Hong Wu and Shu-Chuen Li contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Zhao, FL., Yue, M., Yang, H. et al. Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Qual Life Res 19, 1273–1283 (2010). https://doi.org/10.1007/s11136-010-9697-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-010-9697-2